Accessibility Menu
Arrow-Thin-Down
S&P 500
6,790.57
+0.3%
+19.02
Arrow-Thin-Down
DJI
47,202.28
+0.2%
+117.04
Arrow-Thin-Down
NASDAQ
23,444.68
+0.4%
+96.04
Arrow-Thin-Down
Bitcoin
$103,370.00
-1.1%
-$1,123.11
Arrow-Thin-Down
AAPL
$269.11
-0.3%
-$0.93
Arrow-Thin-Down
AMZN
$247.80
-0.6%
-$1.52
Arrow-Thin-Down
GOOG
$284.00
+2.1%
+$5.94
Arrow-Thin-Down
META
$630.66
+0.5%
+$3.34
Arrow-Thin-Down
MSFT
$512.11
-0.4%
-$2.22
Arrow-Thin-Down
NVDA
$199.86
+0.6%
+$1.17
Arrow-Thin-Down
TSLA
$442.52
-0.4%
-$1.74
Daily Stock GainersDaily Stock LosersMost Active Stocks

How Big Pharma Avoids Billions in Taxes

By Brenton Flynn – Mar 11, 2013 at 8:00PM

Pharmaceutical companies take advantage of tax havens to boost profits for investors. But there is a disadvantage investors might not be aware of.

In the following video, Motley Fool health care bureau chief Brenton Flynn discusses a recent Bloomberg article, which highlights the incredible benefits pharmaceutical companies enjoy through tax management strategies. Brenton tells investors who is profiting and by how much, and why other large-cap health care companies like UnitedHealth Group (UNH 0.89%) and Express Scripts (ESRX +0.00%) are missing out.

Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Express Scripts, Johnson & Johnson, and UnitedHealth Group. The Motley Fool owns shares of Express Scripts and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services